Biocartis Q1 2017 Business Update
(WorldNews Belgium)

PRESS RELEASE REGULATED INFORMATION Thursday, 27 April 2017, 07:00 CEST BIOCARTIS Q1 2017 BUSINESS UPDATE Mechelen, Belgium, 27 April 2017 - Biocartis Group NV (the `Company` or `Biocartis`), an innovative molecular diagnostics company (Euronext Brussels: BCART), today provides a business update for the first quarter of 2017, selected post period events and an outlook for the remainder of the year. Key messages Commercial: Commercial cartridge volume Q1 2017 over 4.5 times Q1 2016 volume. 2017 guidance reiterated: installed base to grow with 250-275 IdyllaTM instruments and 2017 annual commercial cartridge volume to be at least three times 2016 volume. Menu: Continued progress made in...